Lv73
4740 积分 2021-02-21 加入
The future of immune checkpoint therapy
16天前
已完结
Overcoming tyrosine kinase inhibitor resistance in lung cancer brain metastasis with CTLA4 blockade
22天前
已完结
Challenges and opportunities in the PD1/PDL1 inhibitor clinical trial landscape
25天前
已完结
The NKG2A immune checkpoint — a new direction in cancer immunotherapy
29天前
已完结
Emerging targets in cancer immunotherapy
29天前
已完结
Epigenomic heterogeneity as a source of tumour evolution
29天前
已完结
Emerging strategies to investigate the biology of early cancer
29天前
已完结
The hallmarks of cancer immune evasion
1个月前
已完结
Two decades of advances in clinical oncology — lessons learned and future directions
1个月前
已完结
Non-small-cell lung cancer
1个月前
已完结
皖公网安备34019202002308
